Qiang Lu

Company: GenFleet Therapeutics

Job title: Chairman & Founder

Seminars:

Panel Discussion: Does Pan-RAS Hold the Future of Precision Medicine? Exploring Combination Potential & Targeting Novel Isoforms 9:00 am

What is the current scope and strides in developing pan-RAS inhibitors? What combination therapies should be deployed with pan-RAS and how can we inform this? What is the future of pan-RAS? Will it replace mutant-specific therapies?Read more

day: Day One